Fred Lublin
Title
Cited by
Cited by
Year
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ...
Annals of neurology 69 (2), 292-302, 2011
91632011
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis
WI McDonald, A Compston, G Edan, D Goodkin, HP Hartung, FD Lublin, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
84052001
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
CH Polman, SC Reingold, G Edan, M Filippi, HP Hartung, L Kappos, ...
Annals of Neurology: Official Journal of the American Neurological …, 2005
60382005
Defining the clinical course of multiple sclerosis: results of an international survey
FD Lublin, SC Reingold
Neurology 46 (4), 907-911, 1996
43681996
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman, PW O'Connor, E Havrdova, M Hutchinson, L Kappos, ...
New England Journal of Medicine 354 (9), 899-910, 2006
34802006
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
30172018
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double‐blind, placebo-controlled trial
IFNB Multiple Sclerosis Study Group
Neurology 43 (4), 655-655, 1993
26711993
Defining the clinical course of multiple sclerosis The 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
23362014
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ...
New England Journal of Medicine 354 (9), 911-923, 2006
15242006
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
GR Cutter, ML Baier, RA Rudick, DL Cookfair, JS Fischer, J Petkau, ...
Brain 122 (5), 871-882, 1999
12671999
Ocrelizumab versus placebo in primary progressive multiple sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
New England Journal of Medicine 376 (3), 209-220, 2017
11932017
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
New England Journal of Medicine 376 (3), 221-234, 2017
10672017
Disease modifying therapies in multiple sclerosis
DS Goodin, EM Frohman, GP Garmany, J Halper, WH Likosky, FD Lublin
Neurology 58 (2), 169-178, 2002
10402002
Differential diagnosis of suspected multiple sclerosis: a consensus approach
DH Miller, BG Weinshenker, M Filippi, BL Banwell, JA Cohen, ...
Multiple Sclerosis Journal 14 (9), 1157-1174, 2008
7852008
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
PA Calabresi, EW Radue, D Goodin, D Jeffery, KW Rammohan, AT Reder, ...
The Lancet Neurology 13 (6), 545-556, 2014
7022014
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing …
E Havrdova, S Galetta, M Hutchinson, D Stefoski, D Bates, CH Polman, ...
The Lancet Neurology 8 (3), 254-260, 2009
5132009
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
DH Miller, PS Albert, F Barkhof, G Francis, JA Frank, S Hodgkinson, ...
Annals of neurology 39 (1), 6-16, 1996
5061996
Effect of relapses on development of residual deficit in multiple sclerosis
FD Lublin, M Baier, G Cutter
Neurology 61 (11), 1528-1532, 2003
4922003
Interferon beta‐lb in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
IFNB Multiple Sclerosis Study Group and the University of British Columbia ...
Neurology 45 (7), 1277-1285, 1995
4401995
Recommendations from the national multiple sclerosis society clinical outcomes assessment task force
R Rudick, J Antel, C Confavreux, G Cutter, G Ellison, J Fischer, F Lublin, ...
Annals of Neurology: Official Journal of the American Neurological …, 1997
4391997
The system can't perform the operation now. Try again later.
Articles 1–20